Mitrix Bio CEO and Founder on energy is the headline and why it will take a major intervention to win the Degeneration Game.
DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the company mentioned in this video to support its current funding round. Qualifying investors can find out more via the Longevity.Technology investment portal – https://longevity.technology/investment/dashboard/
Last week, we brought you an interview with Tom Benson, the CEO and Founder of Californian longevity biotech start-up Mitrix Bio, in which we discussed mitochondrial dysfunction and the mitochondrial cycle. Today, it’s the turn of longevity interventions and predictions, the role of mitochondrial DNA – and a guest appearance from David and Goliath.
Mitochondrial dysfunction has been implicated in dozens of chronic diseases from Alzheimer’s to CVD and from frailty to immune senescence. Mitrix Bio is targeting that dysfunction with its novel mitlets platform, and when it comes to learning more mitochondria, Mitrix’s founder Tom Benson is a compelling teacher.
——————————
Visit Longevity.Technology – https://bit.ly/3PwtH8Y
Follow Longevity.Technology on:
Twitter – https://bit.ly/3AMIXuq
Facebook – https://bit.ly/3z8H1v5
Instagram – https://bit.ly/3IDvVRX
Linkedin – https://bit.ly/3yIfDmf
source
